Showing results (411-420 of 652) with videos related to
Sort By:
Pageof 66
Clinical and Translational Medicine|April 18, 2015
Psoriasis drug development and GWAS interpretation through in silico analysis of transcription factor binding sitesWilliam R Swindell, Mrinal K Sarkar, Philip E Stuart, et al.The Journal of Laryngology and Otology|February 13, 2013
Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patientsL A Joseph, J A Routledge, M P Burns, et al.Chemotherapy|May 3, 2013
Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: experience outside of a trial settingA J McPartlin, K Mais, C Barker, et al.JB & JS Open Access|April 15, 2022
Disparities in Telemedicine Utilization During COVID-19 Pandemic: Analysis of Demographic Data from a Large Academic Orthopaedic PracticeRichard A Ruberto, Eric A Schweppe, Rifat Ahmed, et al.Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews|August 3, 2021
A Systematic Review of the Orthopaedic Literature on Truncal and Lower Extremity Injuries in Major League Baseball PlayersHasani W Swindell, Josephine R Coury, Nicholas Dantzker, et al.Genesis (New York, N.Y. : 2000)|July 20, 2006
Rx-Cre, a tool for inactivation of gene expression in the developing retinaEric C Swindell, Travis J Bailey, Felix Loosli, et al.Cartilage|June 28, 2022
Rehabilitation Variability Following Osteochondral Autograft and Allograft Transplantation of the KneeStephen G Crowley, Anthony Pedersen, Thomas A Fortney, et al.Journal of Medicinal Chemistry|March 29, 1996
NMR and molecular modeling study of the conformations of taxol 2'-acetate in chloroform and aqueous dimethyl sulfoxide solutionsH J Williams, G Moyna, A I Scott, et al.British Journal of Cancer|February 9, 2005
Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II studyJ W Valle, A Dangoor, J Beech, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 16, 2013
Biochemical outcomes for patients with intermediate risk prostate cancer treated with I-125 interstitial brachytherapy monotherapyAnna Thi Huyen Tran, Paula Mandall, Ric Swindell, et al.Pageof 66